BLUE WATER BIOTECH INC (BWV) Stock Price & Overview
NASDAQ:BWV • US09610B1089
Current stock price
The current stock price of BWV is 0.1802 USD. Today BWV is down by -5.16%. In the past month the price decreased by -41.89%. In the past year, price decreased by -82.5%.
BWV Key Statistics
- Market Cap
- N/A
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.86
- Dividend Yield
- N/A
BWV Stock Performance
BWV Stock Chart
BWV Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to BWV. When comparing the yearly performance of all stocks, BWV is a bad performer in the overall market: 98.49% of all stocks are doing better.
BWV Earnings
BWV Forecast & Estimates
8 analysts have analysed BWV and the average price target is 9.18 USD. This implies a price increase of 4994.34% is expected in the next year compared to the current price of 0.1802.
BWV Groups
Sector & Classification
BWV Financial Highlights
Over the last trailing twelve months BWV reported a non-GAAP Earnings per Share(EPS) of -0.86. The EPS decreased by -2.75% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -65.6% | ||
| ROE | -178.61% | ||
| Debt/Equity | 1.26 |
BWV Ownership
BWV Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 14.11 | 370.255B | ||
| AMGN | AMGEN INC | 15.28 | 188.011B | ||
| GILD | GILEAD SCIENCES INC | 15.19 | 166.661B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 22.34 | 110.013B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.78 | 77.991B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 42.53 | 42.088B | ||
| INSM | INSMED INC | N/A | 31.319B | ||
| BIIB | BIOGEN INC | 11.43 | 26.98B | ||
| NTRA | NATERA INC | N/A | 25.887B | ||
| UTHR | UNITED THERAPEUTICS CORP | 17.5 | 22.916B | ||
| MRNA | MODERNA INC | N/A | 19.573B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 18.333B | ||
| INCY | INCYTE CORP | 11.79 | 17.971B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find more ETFs on the USA exchanges | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About BWV
Company Profile
Blue Water Biotech, Inc. is a biotechnology company, which engages in the research and development of transformational vaccines to prevent infectious diseases worldwide. The company is headquartered in Cincinnati, Ohio and currently employs 12 full-time employees. The company went IPO on 2022-02-18. The firm is focused on developing transformational therapies to address significant health challenges globally. The firm is engaged in developing a streptococcus pneumonia vaccine candidate, designed to specifically prevent highly infectious middle ear infections, known as acute otitis media (AOM), in children, and prevention of pneumonia in the elderly. The firm is also developing a universal flu vaccine that provides protection from all virulent strains in addition to licensing a norovirus (NoV) shell and protrusion (S&P) nanoparticle versatile virus-like particle (VLP) vaccine platform from Cincinnati Children’s Hospital Medical Center to develop vaccines for multiple infectious diseases, including Marburg and monkeypox, among others. In addition, the Company is developing a Chlamydia vaccine candidate with the University of Texas Health Science Center in San Antonio (UT Health).
Company Info
IPO: 2022-02-18
BLUE WATER BIOTECH INC
201 E. Fifth Street, Suite 1900
Cincinnati OHIO US
Employees: 12
Phone: 15136204101
BLUE WATER BIOTECH INC / BWV FAQ
What does BLUE WATER BIOTECH INC do?
Blue Water Biotech, Inc. is a biotechnology company, which engages in the research and development of transformational vaccines to prevent infectious diseases worldwide. The company is headquartered in Cincinnati, Ohio and currently employs 12 full-time employees. The company went IPO on 2022-02-18. The firm is focused on developing transformational therapies to address significant health challenges globally. The firm is engaged in developing a streptococcus pneumonia vaccine candidate, designed to specifically prevent highly infectious middle ear infections, known as acute otitis media (AOM), in children, and prevention of pneumonia in the elderly. The firm is also developing a universal flu vaccine that provides protection from all virulent strains in addition to licensing a norovirus (NoV) shell and protrusion (S&P) nanoparticle versatile virus-like particle (VLP) vaccine platform from Cincinnati Children’s Hospital Medical Center to develop vaccines for multiple infectious diseases, including Marburg and monkeypox, among others. In addition, the Company is developing a Chlamydia vaccine candidate with the University of Texas Health Science Center in San Antonio (UT Health).
Can you provide the latest stock price for BLUE WATER BIOTECH INC?
The current stock price of BWV is 0.1802 USD. The price decreased by -5.16% in the last trading session.
What is the dividend status of BLUE WATER BIOTECH INC?
BWV does not pay a dividend.
What is the ChartMill rating of BLUE WATER BIOTECH INC stock?
BWV has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
What is the analyst forecast for BWV stock?
8 analysts have analysed BWV and the average price target is 9.18 USD. This implies a price increase of 4994.34% is expected in the next year compared to the current price of 0.1802.
How is the valuation of BLUE WATER BIOTECH INC (BWV) based on its PE ratio?
BLUE WATER BIOTECH INC (BWV) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.86).